Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical...
Risk scoring by KidneyIntelX resulted in a 4.5-fold increase in new drug prescriptions (for SGLT2 inhibitors) for high risk compared to low risk patients, an observed reduction of HbA1c levels in the...
View ArticleElementa Labs: 2022 in Review
Take a look at the exciting updates from the past year of Elementa Labs! In 2022, MSIP witnessed the growth of several Elementa portfolio companies from its first two cohorts: the inaugural Fall 2021...
View ArticleMeet the Finalists for the Mount Sinai Pitch Challenge 2023
Get to know the teams competing in this year’s Mount Sinai Pitch Challenge on May 4, the final event in MSIP’s Entrepreneurship Program, as they present healthcare solutions with commercial and...
View ArticleBeeKeeperAI Raises $12.1 Million Series A to Accelerate AI Development on...
BeeKeeperAI, Inc., a pioneer in zero-trust, collaboration software for the development and deployment of artificial intelligence (AI), today announced that it has closed $12.1 million in Series A...
View ArticlePromising Results of Next-Generation Intranasal COVID-19 Booster Vaccine:...
The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle...
View ArticleIcahn School of Medicine at Mount Sinai Licenses Next-Generation Diagnostic...
The Icahn School of Medicine at Mount Sinai has agreed to an exclusive license option with GNOMX Corp. (GNOMX) for epigenetic diagnostic and prognostic technology for infectious diseases. This...
View ArticleNina Bhardwaj, MD, Discusses her Cancer Vaccine Research with MSIP
Meet Nina Bhardwaj, MD, PhD, Professor of Medicine (Hematology and Medical Oncology) and Urology, and Medical Director of the Vaccine and Cell Therapy Laboratory (VCTL) at the Icahn School of Medicine...
View ArticleMSIP Recognizes Researchers and i3 Funding Awardees at Annual Innovation...
The annual Mount Sinai Innovation Awards Ceremony took place on November 6. A hybrid event, the ceremony honored researchers from across the System for various achievements and included awards...
View ArticleHeartSciences Announces Closing of License Agreements with the Icahn School...
Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming...
View Article
